eHealth Earnings Call Transcripts
Fiscal Year 2026
-
The meeting covered director elections, auditor ratification, executive compensation, and an equity plan amendment, all of which were approved by shareholders. No questions were raised during the Q&A session. Final voting results will be filed on Form 8-K.
-
The company is navigating a disruptive Medicare Advantage market by focusing on technology, AI integration, and a shift to lifetime customer relationships. Improved LTV/CAC ratios, reduced acquisition costs, and a strong brand position support a cautious growth outlook, with positive trends in persistency and operational efficiency.
-
First quarter 2026 results exceeded expectations with strong Medicare enrollment and improved unit economics, despite a 22% revenue decline. Strategic cost reductions and the rollout of the lifetime advisory model position the company for sustainable growth and margin expansion in 2027 and beyond.
Fiscal Year 2025
-
Delivered strong 2025 results with 4% revenue growth and nearly 300% net income increase, driven by Medicare segment strength and cost discipline. 2026 will focus on cash flow and margin, with lower revenue expected but improved profitability and continued investment in technology and diversification.
-
Q3 revenue declined 8% year-over-year, but net loss and adjusted EBITDA improved, driven by positive TEL revenue and disciplined cost management. 2025 guidance for net income and adjusted EBITDA was raised, reflecting strong AEP execution and ongoing diversification.
-
A new CEO outlined a strategy focused on omni-channel technology, branded marketing, and diversification to drive growth and profitability in a dynamic Medicare market. Strong financial improvements, scalable digital platforms, and ample liquidity position the company to capitalize on industry disruption and evolving consumer needs.
-
Q2 results exceeded expectations, prompting raised 2025 guidance for revenue and earnings. Medicare segment showed strong retention and profitability, while regulatory changes and industry volatility present both challenges and opportunities.
-
Q1 2025 saw 22% revenue growth, improved profitability, and strong Medicare submissions, with enhanced retention and brand initiatives. Guidance remains unchanged despite outperformance, and regulatory and legal risks are being managed proactively.
Fiscal Year 2024
-
Record Q4 and full-year results driven by Medicare enrollment growth, margin expansion, and operational excellence. 2025 guidance is cautious due to regulatory and market uncertainties, with a focus on diversification and retention.
-
Q3 saw strong Medicare application growth, improved cost structure, and early AEP momentum, with revenue up 9% year-over-year excluding tail revenue. The company reiterated 2024 guidance and remains confident in liquidity and continued above-market enrollment growth.
-
Major transformation since 2022 has improved operational efficiency, diversified revenue, and enhanced customer experience through technology and branding. Positioned for growth in Medicare markets, the company raised guidance and targets strong revenue and margin expansion over the next two years.
-
Q2 2024 saw strong Medicare segment growth, improved profitability metrics, and raised full-year guidance. CEO and CFO transitions are underway, with new retention tools and a shift to fee-based models supporting future growth.